SE9003887L - Cellproliferationsmatris och anvaendning daerav - Google Patents

Cellproliferationsmatris och anvaendning daerav

Info

Publication number: SE9003887L
Authority: SE; Sweden
Prior art keywords: pct; cell proliferation; date jun; proliferation matrix; cruris
Prior art date: 1990-12-06

Application number

SE9003887A

Other languages

English (en)

Other versions

SE501217C2 (sv

Inventor

K Brismar

Original Assignee

Skandigen Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-06

Filing date

1990-12-06

Publication date

1992-06-07

1990-12-06 Application filed by Skandigen Ab filed Critical Skandigen Ab

1990-12-06 Priority to SE9003887A priority Critical patent/SE501217C2/sv

1991-12-05 Priority to PCT/SE1991/000839 priority patent/WO1992010195A1/en

1991-12-05 Priority to JP4500592A priority patent/JPH06503319A/ja

1991-12-05 Priority to AT92900297T priority patent/ATE157253T1/de

1991-12-05 Priority to KR1019930701656A priority patent/KR100206314B1/ko

1991-12-05 Priority to US08/066,165 priority patent/US5432167A/en

1991-12-05 Priority to CA002097181A priority patent/CA2097181A1/en

1991-12-05 Priority to AU90409/91A priority patent/AU649092B2/en

1991-12-05 Priority to DE69127459T priority patent/DE69127459T2/de

1991-12-05 Priority to EP92900297A priority patent/EP0560845B1/en

1992-06-07 Publication of SE9003887L publication Critical patent/SE9003887L/sv

1994-12-12 Publication of SE501217C2 publication Critical patent/SE501217C2/sv

Links

230000004663 cell proliferation Effects 0.000 title abstract 3
239000011159 matrix material Substances 0.000 title abstract 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 2
208000010392 Bone Fractures Diseases 0.000 abstract 2
230000008321 arterial blood flow Effects 0.000 abstract 2
206010012601 diabetes mellitus Diseases 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
229920002674 hyaluronan Polymers 0.000 abstract 2
229960003160 hyaluronic acid Drugs 0.000 abstract 2
230000001771 impaired effect Effects 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
206010011985 Decubitus ulcer Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Materials Engineering (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Mattresses And Other Support Structures For Chairs And Beds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

SE9003887A 1990-12-06 1990-12-06 Cellproliferationsmatris och användning därav SE501217C2 (sv)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
SE9003887A SE501217C2 (sv)	1990-12-06	1990-12-06	Cellproliferationsmatris och användning därav
PCT/SE1991/000839 WO1992010195A1 (en)	1990-12-06	1991-12-05	Cell proliferation matrix and use thereof
JP4500592A JPH06503319A (ja)	1990-12-06	1991-12-05	細胞増殖マトリックス及びその用法
AT92900297T ATE157253T1 (de)	1990-12-06	1991-12-05	Zellprofilerationsmatritze und ihre verwendung
KR1019930701656A KR100206314B1 (ko)	1990-12-06	1991-12-05	세포증식 매트릭스
US08/066,165 US5432167A (en)	1990-12-06	1991-12-05	Cell proliferation matrix and use thereof
CA002097181A CA2097181A1 (en)	1990-12-06	1991-12-05	Cell proliferation matrix and use thereof
AU90409/91A AU649092B2 (en)	1990-12-06	1991-12-05	Cell proliferation matrix and use thereof
DE69127459T DE69127459T2 (de)	1990-12-06	1991-12-05	Zellprofilerationsmatritze und ihre verwendung
EP92900297A EP0560845B1 (en)	1990-12-06	1991-12-05	Cell proliferation matrix and use thereof

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9003887A SE501217C2 (sv)	1990-12-06	1990-12-06	Cellproliferationsmatris och användning därav

Publications (2)

Publication Number	Publication Date
SE9003887L true SE9003887L (sv)	1992-06-07
SE501217C2 SE501217C2 (sv)	1994-12-12

Family

ID=20381109

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9003887A SE501217C2 (sv)	1990-12-06	1990-12-06	Cellproliferationsmatris och användning därav

Country Status (10)

Country	Link
US (1)	US5432167A (sv)
EP (1)	EP0560845B1 (sv)
JP (1)	JPH06503319A (sv)
KR (1)	KR100206314B1 (sv)
AT (1)	ATE157253T1 (sv)
AU (1)	AU649092B2 (sv)
CA (1)	CA2097181A1 (sv)
DE (1)	DE69127459T2 (sv)
SE (1)	SE501217C2 (sv)
WO (1)	WO1992010195A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1260148B (it) *	1992-04-17	1996-03-28	Fidia Spa	Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
US5550112A (en) *	1992-12-30	1996-08-27	Patent Biopharmaceutics, Inc.	Hyaluronic acid-urea pharmaceutical compositions and uses
CA2165826A1 (en) *	1993-07-01	1995-01-12	Alain E. Lagarde	Hyaluronic acid fragments and their therapeutic use
US6221854B1 (en) *	1996-03-05	2001-04-24	Orquest, Inc.	Method of promoting bone growth with hyaluronic acid and growth factors
US20110207666A1 (en) *	1996-03-05	2011-08-25	Depuy Spine, Inc.	Method of promoting bone growth with hyaluronic acid and growth factors
EP1129683A4 (en)	1998-11-10	2002-06-19	Denki Kagaku Kogyo Kk	HYALURONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL MATERIALS CONTAINING THIS
FR2811671B1 (fr) *	2000-07-17	2003-02-28	Corneal Ind	Hydrogel de polymere(s), resistant a la biodegration, preparation et utilisation a titre de support de regeneration tissulaire
WO2003094937A1 (en) *	2002-05-09	2003-11-20	Medigenes	A pharmaceutical composition for treatment of wounds containing blood plasma or serum
ITMI20051230A1 (it) *	2005-06-29	2006-12-30	Pharmaperoducts Uk Ltd	Composizioni farmaceutiche e cosmetiche contenenti colostro tocoferoli ossido di zinco e acido ialuronico
US7323184B2 (en) *	2005-08-22	2008-01-29	Healagenics, Inc.	Compositions and methods for the treatment of wounds and the reduction of scar formation
WO2008094910A2 (en) *	2007-01-30	2008-08-07	Cypress Pharmaceutical, Inc.	Hyaluronate compositions
FR2954165B1 (fr) *	2009-12-18	2012-01-13	Jean-Noel Thorel	Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
WO2021112568A1 (ko)	2019-12-03	2021-06-10	삼성전자 주식회사	광학 제어 스위치 및 이를 포함하는 전자 장치
RU2721303C1 (ru) *	2019-12-03	2020-05-18	Самсунг Электроникс Ко., Лтд.	Оптически-управляемый переключатель миллиметрового диапазона со встроенным источником света, основанный на линии передачи с полупроводниковой подложкой

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US5166331A (en) *	1983-10-10	1992-11-24	Fidia, S.P.A.	Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
LU85582A1 (fr) *	1983-10-11	1985-06-04	Fidia Spa	Fractions d'acide hyaluronique ayant une activite pharmaceutique,procedes pour leur preparation et compositions pharmaceutiques les contenant
JPS60251898A (ja) *	1984-05-25	1985-12-12	Shiseido Co Ltd	醗酵法によるヒアルロン酸の製造方法
US5133755A (en) *	1986-01-28	1992-07-28	Thm Biomedical, Inc.	Method and apparatus for diodegradable, osteogenic, bone graft substitute device
JPH072117B2 (ja) *	1986-10-09	1995-01-18	三菱レイヨン株式会社	ヒアルロン酸の製造法
US5041138A (en) *	1986-11-20	1991-08-20	Massachusetts Institute Of Technology	Neomorphogenesis of cartilage in vivo from cell culture
NZ226171A (en) *	1987-09-18	1990-06-26	Ethicon Inc	Gel formulation containing polypeptide growth factor
DK505588D0 (da) *	1988-02-26	1988-09-09	Jesper Hamburger	Middel og anvendelse af samme
US5196185A (en) *	1989-09-11	1993-03-23	Micro-Collagen Pharmaceutics, Ltd.	Collagen-based wound dressing and method for applying same
US5180808A (en) *	1989-11-27	1993-01-19	La Jolla Cancer Research Foundation	Versican core protein, nucleic acid sequences encoding the same, nucleic acid probes, anti-versican antibodies, and methods of detecting the same
AU662491B2 (en) *	1990-09-25	1995-09-07	Smithkline Beecham Corporation	Medium for culture of mammalian cells
US5234914A (en) *	1991-06-11	1993-08-10	Patent Biopharmaceutics, Inc.	Methods of treating hemorrhoids and anorecial disease

1990
- 1990-12-06 SE SE9003887A patent/SE501217C2/sv unknown
1991
- 1991-12-05 AU AU90409/91A patent/AU649092B2/en not_active Ceased
- 1991-12-05 WO PCT/SE1991/000839 patent/WO1992010195A1/en not_active Ceased
- 1991-12-05 KR KR1019930701656A patent/KR100206314B1/ko not_active Expired - Fee Related
- 1991-12-05 DE DE69127459T patent/DE69127459T2/de not_active Expired - Fee Related
- 1991-12-05 US US08/066,165 patent/US5432167A/en not_active Expired - Fee Related
- 1991-12-05 CA CA002097181A patent/CA2097181A1/en not_active Abandoned
- 1991-12-05 JP JP4500592A patent/JPH06503319A/ja not_active Withdrawn
- 1991-12-05 EP EP92900297A patent/EP0560845B1/en not_active Expired - Lifetime
- 1991-12-05 AT AT92900297T patent/ATE157253T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69127459T2 (de)	1998-01-02
WO1992010195A1 (en)	1992-06-25
JPH06503319A (ja)	1994-04-14
AU649092B2 (en)	1994-05-12
KR930702995A (ko)	1993-11-29
SE501217C2 (sv)	1994-12-12
US5432167A (en)	1995-07-11
AU9040991A (en)	1992-07-08
DE69127459D1 (de)	1997-10-02
ATE157253T1 (de)	1997-09-15
CA2097181A1 (en)	1992-06-07
KR100206314B1 (ko)	1999-07-01
EP0560845B1 (en)	1997-08-27
EP0560845A1 (en)	1993-09-22

Similar Documents

Publication	Publication Date	Title
SE9003887L (sv)	1992-06-07	Cellproliferationsmatris och anvaendning daerav
BR9813373A (pt)	2000-10-03	Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
ATE231519T1 (de)	2003-02-15	Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
EA200001175A1 (ru)	2001-06-25	Бензотиофены, бензофураны и индолы, полезные в лечении устойчивости к инсулину и гипергликемии
UA41989C2 (uk)	2001-10-15	Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE480256T1 (de)	2010-09-15	Plazentäre alkalische phosphatase zur diabeteskontrolle
ITPD920071A1 (it)	1993-10-17	Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
KR960022542A (ko)	1996-07-18	광학 활성 벤조티에핀 유도체, 그의 제조방법 및 용도
DE68904462D1 (de)	1993-03-04	4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
KR950700079A (ko)	1995-01-16	이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DE69024053D1 (de)	1996-01-18	Behandlung zur ermässigung von ödem und muskelschäden.
NO893135L (no)	1990-02-05	Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
DE69501359D1 (de)	1998-02-12	Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
KR960003729A (ko)	1996-02-23	항과혈당증 작용을 지닌 약제
DE69634487D1 (de)	2005-04-21	Verfahren zur behandlung navikularer krankheiten bei pferden
ATE78824T1 (de)	1992-08-15	Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
Slocombe et al.	1984	Evaluation of ivermectin against later fourth-stage Strongylus vulgaris in ponies at two and five weeks after treatment
ATE86112T1 (de)	1993-03-15	Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
ATE79034T1 (de)	1992-08-15	Behandlung von viruskrankheiten.
NO982935D0 (no)	1998-06-24	Hyaluronsyre reseptor bindende middel og anvendelse derav
KR890012942A (ko)	1989-09-20	5-치환된 오르니틴 유도체
DE59409413D1 (de)	2000-08-03	Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE69428797D1 (de)	2001-11-29	Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE69530771D1 (de)	2003-06-18	Verwendung von 2-phenyl-3-aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
KR910009255A (ko)	1991-06-28	과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체